Advertisement
Advertisement
U.S. Markets close in 1 hr 35 mins
Advertisement
Advertisement
Advertisement
Advertisement

Talaris Therapeutics, Inc. (TALS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.63+0.13 (+0.84%)
As of 2:18PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close15.50
Open15.45
Bid15.59 x 900
Ask15.90 x 1100
Day's Range15.28 - 15.96
52 Week Range11.39 - 19.82
Volume6,879
Avg. Volume41,556
Market Cap667.107M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est29.25
  • GlobeNewswire

    Talaris Therapeutics to Participate at Two Upcoming Virtual Investor Conferences

    BOSTON and LOUISVILLE, Ky., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant blood, immune and metabolic disorders, today announced that members of its senior management team will participate at the following investor conferences: Morgan Stanley Virtual

  • GlobeNewswire

    Talaris Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update

    On track to provide FREEDOM-1 initial clinical update, initiate FREEDOM-2 and FREEDOM-3 trials, and to disclose additional indication for FCR001 before year-endBOSTON and LOUISVILLE, Ky., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant blood, immune and

  • Simply Wall St.

    Here's What Talaris Therapeutics, Inc.'s (NASDAQ:TALS) Shareholder Ownership Structure Looks Like

    The big shareholder groups in Talaris Therapeutics, Inc. ( NASDAQ:TALS ) have power over the company. Insiders often...

Advertisement
Advertisement